Amelanotic lentigo maligna melanoma of the face: a case report and review of the literature

1997 ◽  
Vol 22 (4) ◽  
pp. 177-179 ◽  
Author(s):  
S. CLIFF ◽  
M. OTTER ◽  
C.A. HOLDEN
2014 ◽  
Vol 6 (3) ◽  
pp. 114-117
Author(s):  
Ilson Sepúlveda ◽  
Michael Frelinghuysen ◽  
Cesar García ◽  
M Loreto Spencer ◽  
Enrique Platín ◽  
...  

ABSTRACT We report on a patient who presented with pain and swelling to the left maxillary region of the face. A biopsy of the area was performed and subsequently diagnosed as maxillary carcinosarcoma (CCS). After reviewing the pathology results and the size of the tumor, it was decided that a radical dissection, followed by radiation therapy was the best option. How to cite this article Sepúlveda I, Frelinghuysen M, García C, Spencer ML, Platín E, Alarcon J, Ulloa D. Maxillary Carcinosarcoma: A Case Report and Review of the Literature. Int J Otorhinolaryngol Clin 2014;6(3):114117.


2011 ◽  
Vol 135 (7) ◽  
pp. 838-841
Author(s):  
Jon A. Reed ◽  
Christopher R. Shea

Abstract Context.—Cutaneous primary invasive malignant melanoma often is classified by its histologic appearance. Major recognized histologic subtypes of melanoma include superficial spreading, lentigo maligna melanoma, nodular, and acral lentiginous. More recently, it has been shown that most primary invasive melanomas harbor nonrandom genetic or biochemical aberrations that correlate with anatomic site or with the amount of cutaneous exposure to sunlight. It also is generally accepted that most primary invasive melanomas are preceded by an intraepidermal atypical melanocytic proliferation that lacks invasive capability (melanoma in situ). Objective.—To focus on lentigo maligna, the preinvasive/in situ form of melanoma located on chronically sun-damaged skin. Data Sources.—Review of the literature and the authors' personal experiences. Conclusions.—A better understanding of the earliest stage of melanoma progression, including the contribution of chronic exposure to ultraviolet radiation, may lead to improved classification schemes that direct more effective targeted or personalized therapies for patients.


2016 ◽  
Vol 26 (5) ◽  
pp. 465-469 ◽  
Author(s):  
François Kuonen ◽  
Josef Aschwanden ◽  
Dominick J. Dimaio ◽  
Dirk M. Elston ◽  
Michel Gilliet ◽  
...  

2004 ◽  
Vol 43 (12) ◽  
pp. 931-935 ◽  
Author(s):  
Claudia Jimena Perafán Riveros ◽  
Maria Filomena Bejarano Gavilán ◽  
Luis Fernando Sayago França ◽  
Mírian Nacagami Sotto ◽  
Maria Denise Fonseca Takahashi

Sign in / Sign up

Export Citation Format

Share Document